Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Debt to Equity: 2010-2024

Historic Debt to Equity for OptimizeRx (OPRX) over the last 5 years, with FY2024 value amounting to $0.28.

  • OptimizeRx's Debt to Equity fell 2542.46% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.23, marking a year-over-year decrease of 2542.46%. This contributed to the annual value of $0.28 for FY2024, which is 202.86% down from last year.
  • Latest data reveals that OptimizeRx reported Debt to Equity of $0.28 as of FY2024, which was down 202.86% from $0.29 recorded in FY2023.
  • In the past 5 years, OptimizeRx's Debt to Equity ranged from a high of $0.29 in FY2023 and a low of $0.01 during FY2020
  • In the last 3 years, OptimizeRx's Debt to Equity had a median value of $0.28 in 2024 and averaged $0.19.
  • Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 5576.62% in 2020, then tumbled by 202.86% in 2024.
  • OptimizeRx's Debt to Equity (Annual) stood at $0.01 in 2020, then soared by 4906.07% to $0.29 in 2023, then fell by 2.03% to $0.28 in 2024.
  • Its Debt to Equity stands at $0.28 for FY2024, versus $0.29 for FY2023 and $0.01 for FY2020.